Comerica Securities’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,152
Closed -$202K 455
2023
Q2
$202K Buy
+2,152
New +$168K 0.01% 462
2023
Q1
Sell
-1,625
Closed -$80.5K 773
2022
Q4
$80.5K Buy
+1,625
New +$66.4K 0.01% 628

Other funds holding EXAS

Comerica Securities's EXAS Position: Q3 2023 in Review

Comerica Securities sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 2,152 shares — an estimated $202K sold.

Comerica Securities first reported a position in EXAS in Q4 2022 and held it in 2 quarters. The position peaked at $202K in Q2 2023. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Comerica Securities reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Comerica Securities sold 2,152 Exact Sciences shares in Q3 2023, an estimated $202K.
  • Comerica Securities first reported a position in Exact Sciences in Q4 2022 and held it in 2 quarters.
  • Comerica Securities's Exact Sciences position peaked at $202K in Q2 2023.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.